# Perineural Dexmedetomidine and Femoral Nerve Block

> **NCT01964040** · PHASE4 · UNKNOWN · sponsor: **Cairo University** · enrollment: 45 (estimated)

## Conditions studied

- Onset and Duration of Sensory and Motor Block of Femoral Nerve,
- Visual Analogue Pain Scores,
- Time to First Request of Rescue Analgesics,
- Total Morphine Consumption in 24 Hours

## Interventions

- **DRUG:** peri-neural dexmedetomidine as adjuvant to bupivacaine in femoral nerve block

## Key facts

- **NCT ID:** NCT01964040
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2013-12
- **Final completion:** 2014-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2013-10-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01964040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01964040, "Perineural Dexmedetomidine and Femoral Nerve Block". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01964040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*